The European Molecular Biology Organization (EMBO)will launch a new journal focusing on the interface between molecular biology and clinical research. The EMBO Molecular Medicine journal, to be released starting 2009, will publish studies on molecular insights into cellular and systemic processes underlying defined human diseases as well as potential clinical applications for diagnosis, prevention and therapy.
“EMBO Molecular Medicine offers a unique opportunity to broadly distribute new findings in biomedical research and to strengthen links between clinicians and molecular biologists,” said Hermann Bujard, EMBO Director. “We hope that published papers will lead to advances that will improve the detection, diagnosis and clinical management of diseases.” Submissions are invited from research groups at universities, independent research laboratories and pharmaceutical and biotechnology companies worldwide.
Research groups from universities, independent research institutions and pharma/biotech companies are invited to submit their manuscripts for publication. The journal offers free access to all content for the first two years of publication.